Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAdam S. Darwich, Amin Rostami‐Hodjegan, Jean‐Luc Reny et al.|The Annual Review of Pharmacology and Toxicology|2020Cited by 179
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine MetabolismPorntipa Korprasertthaworn, Andrew Rowland, Thomas M. Polasek et al.|Drug Metabolism and Disposition|2015Cited by 45
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophreniaVidya Perera, Andrew J. McLachlan, Junzhe Xu et al.|Expert Opinion on Drug Metabolism & Toxicology|2013Cited by 39